Proposes the use of the SAF score and a histopathological algorithm to categorize liver lesions in morbidly obese patients with NAFLD.
Should not yet change practice; leaves open prospective validation of the SAF algorithm in obese NAFLD.
We propose a simple but robust algorithm for categorizing liver lesions in NAFLD patients. Because liver lesions in obese patients may display a continuous spectrum of histologic lesions, we suggest describing liver lesions using the SAF score.
No takes yet. Share an insight, caveat, or question.
Bédossa et al. (2012) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: